Paired design study by real-time PCR: MiR-378* and miR-145 are potent early diagnostic biomarkers of human colorectal cancer

BMC Cancer

Volumn 15, Issue 1, 2015, Pages

  Peng, Juan ^a   Xie, Zhengyong ^b   Cheng, Liyang ^b   Zhang, Yuxin ^b   Chen, Junyong ^b   Yu, Hongping ^a   Li, Zehang ^b   Kang, Huixing ^b  

^a GUILIN MEDICAL UNIVERSITY   (China)

^b GUANGZHOU GENERAL HOSPITAL OF GUANGZHOU MILITARY COMMAND   (China)

Author keywords

Colorectal cancer; Early diagnosis; MiRNA

Indexed keywords

MICRORNA; MICRORNA 145; MICRORNA 378; TUMOR MARKER; UNCLASSIFIED DRUG; MIRN145 MICRORNA, HUMAN; MIRN378 MICRORNA, HUMAN;

ADULT; ARTICLE; CANCER PROGNOSIS; CANCER SCREENING; CANCER STAGING; CLINICAL ARTICLE; CLINICAL FEATURE; COLORECTAL CANCER; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DISCRIMINANT ANALYSIS; DOWN REGULATION; EARLY DIAGNOSIS; FALSE POSITIVE RESULT; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GENETIC ASSOCIATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; REAL TIME POLYMERASE CHAIN REACTION; RECEIVER OPERATING CHARACTERISTIC; RNA ANALYSIS; SENSITIVITY AND SPECIFICITY; STUDY DESIGN; UPREGULATION; AGED; BIOSYNTHESIS; COLORECTAL TUMOR; EARLY CANCER DIAGNOSIS; GENETICS; MIDDLE AGED; PATHOLOGY; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BIOMARKERS, TUMOR; COLORECTAL NEOPLASMS; EARLY DETECTION OF CANCER; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MICRORNAS; MIDDLE AGED; NEOPLASM STAGING;

EID: 85019230161     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/s12885-015-1123-2     Document Type: Article

References (24)

1. Buechner J, Henriksen JR, Haug BH, Tømte E, Flaegstad T, Einvik C. Inhibition of mir-21, which is up-regulated during MYCN knockdown-mediated differentiation, does not prevent differentiation of neuroblastoma cells. Differentiation. 2011;81(1):25-34.
2. Bandrés E, Cubedo E, Agirre X, Malumbres R, Zárate R, Ramirez N, et al. Identification by Real-time PCR of 13 mature microRNAs differentially expressed in colorectal cancer and non-tumoral tissues. Mol Cancer. 2006;5:29.
3. Ma Y, Zhang P, Yang J, Liu Z, Yang Z, Qin H. Candidate microRNA biomarkers in human colorectal cancer: systematic review profiling studies and experimental validation. Int J Cancer. 2012;130(9):2077-87.
4. Kulwichit W, Nilgate S, Chatsuwan T, Krajiw S, Unhasuta C, Chongthaleong A. Accuracies of Leuconostoc phenotypic identification: a comparison of API systems and conventional phenotypic assays. BMC Infect Dis. 2007;7:69.
5. Ehli EA, Lengyel-Nelson T, Hudziak JJ, Davies GE. Using a commercially available DNA extraction kit to obtain high quality human genomic DNA suitable for PCR and genotyping from 11-year-old saliva saturated cotton spit wads. BMC Res Notes. 2008;1:133.
6. Goldschmidt P, Balloy T, Degorge S, Benallaoua D, Batellier L, Koskas F, et al. New ultra rapid test for detection of bacteria. Pathol Biol (Paris). 2011;59(5):248-55.
7. Fujimaki S, Funato T, Fujiwara J, Satoh J, Miura T, Kaku M, et al. The construction of a standard RNA synthesized for quantitative RT-PCR system. Rinsho Byori. 2000;48(1):54-9.
8. Leite KR1, Tomiyama A, Reis ST, Sousa-Canavez JM, Sañudo A, Camara-Lopes LH, et al. MicroRNA expression profiles in the progression of prostate cancer-from high-grade prostate intraepithelial neoplasia to metastasis. Urol Oncol. 2013;31(6):796-801.
9. Bonney H. An investigation of the use of discriminant analysis for the classification of blade edge type from cut marks made by metal and bamboo blades. Am J Phys Anthropol. 2014;154(4):575-84.
10. Bestas R, Kaplan MA, Isikdogan A. The correlation between serum VEGF levels and known prognostic risk factors in colorectal carcinoma. Hepatogastroenterology. 2014;61(130):267-71.
11. Kim JH1, Rhee YY, Bae JM, Cho NY, Kang GH. Loss of CDX2/CK20 expression is associated with poorly differentiated carcinoma, the CpG island methylator phenotype, and adverse prognosis in microsatellite-unstable colorectal cancer. Am J Surg Pathol. 2013;37(10):1532-41.
12. Pagliuca A, Valvo C, Fabrizi E, di Martino S, Biffoni M, Runci D, et al. Analysis of combined action of miR-143 and miR-145 on oncogenic pathways in colorectal cancer cells reveals a coordinate program of gene repression. Oncogene. 2012;32(40):4806-13.
13. Zhang GJ, Zhou H, Xiao HX, Li Y, Zhou T. MiR-378 is an independent prognostic factor and inhibits cell growth and invasion in colorectal cancer. BMC Cancer. 2014;14:109.
14. Li H, Dai S, Zhen T, Shi H, Zhang F, Yang Y, et al. Clinical and biological significance of miR-378a-3p and miR-378a-5p in colorectal cancer. Eur J Cancer. 2014;50(6):1207-21.
15. Christensen LL, Holm A, Rantala J, Kallioniemi O, Rasmussen MH, Ostenfeld MS, et al. Functional Screening Identifies miRNAs Influencing Apoptosis and Proliferation in Colorectal Cancer. PLoS One. 2014;9(6):e96767.
16. Cui SY, Wang R, Chen LB. MicroRNA-145:a potent tumour suppressor that regulate multiple cellular pathways. J Cell Mol Med. 2014;18(10):1913-26.
17. Hou Y, Wang X, Chen Y, Mu S. MicroRNA-145 as a ideal bimaker for the diagnosis of various carcinomas. Tumour Biol. 2014;12(10):1010-4283.
18. Toden S, Okugawa Y, Jascur T, Wodarz D, Komarova NL, Buhrmann C, et al. Curcumin mediates chemosensitization to 5-fluorouracil through miRNA-induced suppression of epithelial-to-mesenchymal transition in chemoresistant colorectal cancer. Carcinogenesis. 2015;10:1093.
19. Fei B, Wu H. MiR-378 inhibits progression of human gastric cancer MGC-803 cells by targeting MAPK1 in vitro. Oncol Res. 2012;20(12):557-64.
20. Hupkes M, Sotoca AM, Hendriks JM, van Zoelen EJ, Dechering KJ. MicroRNA miR-378 promotes BMP2-induced osteogenic differentiation of mesenchymal progenitor cells. BMC Mol Biol. 2014;15:1.
21. Kulyté A, Lorente-Cebrián S, Gao H, Mejhert N, Agustsson T, Arner P, et al. MicroRNA profiling links miR-378 to enhanced adipocyte lipolysis in human cancer cachexia. Am J Physiol Endocrinol Metab. 2014;306(3):E267-74.
22. Panza A. Peroxisome proliferator-activated receptor Γ-mediated induction of microRNA-145 opposes tumor phenotype in colorectal cancer. Biochim Biophy Acta. 2014;1843(6):1225-36.
23. Yu BL, Peng XH, Zhao FP, Liu X, Lu J, Wang L, et al. MicroRNA-378 functions as an onco-miR in nasopharyngeal carcinoma by repressing TOB2 expression. Int J Oncol. 2014;44(4):1215-22.
24. Wang D, Yan X, Xia M, Yang Y, Li D, Li X, et al. Coenzyme Q10 Promotes Macrophage Cholesterol Efflux by Regulation of the Activator Protein-1/MicroRNA-378/ATP-Binding Cassette Transporter G1-Signaling Pathway. Arterioscler Thromb Vasc Biol. 2014;12(10):1010-4283.